Heron Therapeutics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1983-01-01
- Employees
- 126
- Market Cap
- $292.7M
- Website
- http://www.herontx.com
Pediatric Postoperative Analgesia Herniorrhaphy Study
- Conditions
- Analgesia
- Interventions
- First Posted Date
- 2019-04-19
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Heron Therapeutics
- Registration Number
- NCT03922048
Herniorrhaphy Study for Opioid Elimination
- Conditions
- Analgesia
- Interventions
- First Posted Date
- 2019-04-08
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 115
- Registration Number
- NCT03907176
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸UPMC Shadyside Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸UPMC Passavant, Pittsburgh, Pennsylvania, United States
Phase 2 Bunionectomy HTX-011 Administration Study
- Conditions
- Postoperative Pain
- Interventions
- First Posted Date
- 2018-10-24
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 78
- Registration Number
- NCT03718039
- Locations
- 🇺🇸
Endeavor Clinical Trials, LLC, San Antonio, Texas, United States
Bupivacaine HCl PK and Safety in Augmentation Mammoplasty
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT03705065
- Locations
- 🇺🇸
Hermann Drive Surgical Hospital, Houston, Texas, United States
Phase 2 Herniorrhaphy Study for Opioid Elimination
- Conditions
- Postoperative Pain
- Interventions
- Drug: HTX-011Device: Luer lock applicatorDevice: Vial access deviceDrug: IbuprofenDrug: AcetaminophenDrug: Ketorolac
- First Posted Date
- 2018-10-04
- Last Posted Date
- 2021-10-25
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 63
- Registration Number
- NCT03695367
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
Bunionectomy Study for Postoperative Analgesia (EPOCH 1)
- Conditions
- Postoperative Pain
- Interventions
- Drug: HTX-011Drug: Saline PlaceboDrug: Bupivacaine HClDevice: Luer-lock applicatorDevice: Vial access device
- First Posted Date
- 2017-09-28
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 412
- Registration Number
- NCT03295721
- Locations
- 🇺🇸
Springhill Medical Center, Mobile, Alabama, United States
🇺🇸Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸Trovare Clinical Research, Inc., Bakersfield, California, United States
Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)
- Conditions
- Postoperative Pain
- Interventions
- Drug: HTX-011Drug: Saline placeboDrug: Bupivacaine HClDevice: Luer-lock applicatorDevice: Vial access device
- First Posted Date
- 2017-08-02
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 418
- Registration Number
- NCT03237481
- Locations
- 🇺🇸
Trovare Clinical Research, Inc., Bakersfield, California, United States
🇺🇸Alliance Research Centers, Laguna Hills, California, United States
🇺🇸Westside Surgical Hospital, Houston, Texas, United States
Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia
- Conditions
- Postoperative Pain
- Interventions
- First Posted Date
- 2017-01-10
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 285
- Registration Number
- NCT03015532
Phase 2B Upper Extremity Nerve Block Study
- Conditions
- Postoperative Pain
- Interventions
- First Posted Date
- 2017-01-05
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 243
- Registration Number
- NCT03011333
Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
- Conditions
- Postoperative PainBunions
- Interventions
- Drug: HTX-002Biological: Saline PlaceboDrug: HTX-011ADrug: HTX-011BDrug: Bupivacaine HClDrug: HTX-009
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 430
- Registration Number
- NCT02762929